Total Funding
33
63
Total FundingSeries B raised
Growth Score 33 in past quarter
1 pts
Heat Score 63 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
98368
FEROKA is developing transdermal drug delivery system solutions with multi-layer microneedle, quick-dissolving and 3D printing technology
- SangYong Kim: Chief Development Officer
- H.S. Kim: Chief Executive Officer
About the Company
Feroka is a BioTech company developing multi-layer micro-needle-patch platform that is capable of drug delivery in exact volumes. The microneedle contains a shaft: It melts rapidly under the skin, separating the patch from the needle layer quickly, making it convenient for the user to remove the patch with ease. Furthermore, as long as the shaft is
present, a layer of needles with drugs can be delivered to any layer, whether that be epidermis, dermis, or others.
